Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B8ZR
|
|||
| Former ID |
DIB001308
|
|||
| Drug Name |
NTO-1151
|
|||
| Indication | Cervical cancer [ICD-11: 2C77.0; ICD-9: 180] | Phase 2 | [1] | |
| Company |
Nanotherapeutics; national cancer institute
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ribonuclease (RNase) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Nanotherapeutics. | |||
| REF 2 | Clinical pipeline report, company report or official report of Nanotherapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.